Total hip BMD · premenopausal women (age 18−47.3 years)
1 finding from 1 review
Lumbar spine bone mineral density (BMD) · premenopausal women (age 18−47.3 years)
1 finding from 1 review
Quality of life · premenopausal women (age 18−47.3 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vertebral fracture · premenopausal women (age 18−47.3 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐vertebral fractures · premenopausal women (age 18−47.3 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability: total withdrawals · premenopausal women (age 18−47.3 years)
Calcium showed no clear difference in withdrawals from the study for any reason compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · premenopausal women (age 18−47.3 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total hip BMD · premenopausal women (ages 18–36 years)
1 finding from 1 review
Lumbar spine bone mineral density (BMD) · premenopausal women (ages 18–36 years)
1 finding from 1 review
Quality of life · premenopausal women (ages 18–36 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vertebral fracture · premenopausal women (ages 18–36 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐vertebral fractures · premenopausal women (ages 18–36 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability: total withdrawals · premenopausal women (ages 18–36 years)
Calcium and vitamin D showed no clear difference in withdrawals from the study for any reason compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events · premenopausal women (ages 18–36 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Migraine frequency Number of attacks · patients with Raynaud's phenomenon
1 finding from 1 review
Duration of attacks · patients with Raynaud's phenomenon
1 finding from 1 review
Severity of attacks · patients with Raynaud's phenomenon
1 finding from 1 review
Pain intensity (0‐10cm visual analogue scale) · patients with Raynaud's phenomenon
1 finding from 1 review
Patient global Disability due to Raynaud's assessed on a 10‐cm visual analogue scale (0 = no disability, 10 = maximal disability) · patients with Raynaud's phenomenon
1 finding from 1 review
Withdrawals due to adverse events · patients with Raynaud's phenomenon
Calcium channel blockers showed no clear difference in number of withdrawals due to adverse events Number of participants… compared with placebo (low certainty).
1 finding from 1 review